Total for the last 12 months
number of access : ?
number of downloads : ?
ID 118959
Author
Inada, Ken Kitasato University
Fukumoto, Kentaro Iwate Medical University
Hasegawa, Naomi National Center of Neurology and Psychiatry
Yasuda, Yuka National Center of Neurology and Psychiatry|Life Grow Brilliant Mental Clinic
Yamada, Hisashi Hyogo Medical College|National Center of Neurology and Psychiatry
Hori, Hikaru Fukuoka University
Ichihashi, Kayo University of Tokyo
Iida, Hitoshi Fukuoka University
Ohi, Kazutaka Gifu University
Muraoka, Hiroyuki Tokyo Women's Medical University|Kitasato University
Kodaka, Fumitoshi The Jikei University School of Medicine
Ide, Kenta University of Occupational and Environmental Health
Hashimoto, Naoki Hokkaido University
Ogasawara, Kazuyoshi Nagoya University
Atake, Kiyokazu Nippon Telegraph and Telephone West Corporation
Takaesu, Yoshikazu University of the Ryukyus
Nagasawa, Tatsuya Kanazawa Medical University
Komatsu, Hiroshi Tohoku University
Okada, Tsuyoshi Jichi Medical University
Furihata, Ryuji Kyoto University
Kido, Mikio Kido Clinic|University of Toyama
Kikuchi, Saya Tohoku University
Kubota, Chika National Center of Neurology and Psychiatry
Makinodan, Manabu Nara Medical University
Ochi, Shinichiro Ehime University|University of Alabama at Birmingham
Takeshima, Masahiro Akita University
Yamagata, Hirotaka Yamaguchi University
Matsumoto, Junya National Center of Neurology and Psychiatry
Miura, Kenichiro National Center of Neurology and Psychiatry
Usami, Masahide Kohnodai Hospital
Kishimoto, Taishiro Keio University
Onitsuka, Toshiaki Kyushu University
Katsumoto, Eiichi Katsumoto Mental Clinic
Hishimoto, Akitoyo Yokohama City University
Yasui-Furukori, Norio Dokkyo Medical University
Watanabe, Koichiro Kyorin University
Hashimoto, Ryota National Center of Neurology and Psychiatry
Keywords
clinical practice guideline
individual fitness score (IFS)
prescription
quality indicator
schizophrenia
Content Type
Journal Article
Description
Aims: The Guidelines for the Pharmacotherapy of Schizophrenia were established to improve the quality of medical care, and the EGUIDE project was conducted to train clinicians on guideline usage. A quality indicator (QI) was established to measure the prevalence of the guidelines, and a survey was conducted, which revealed a gap between the guidelines and actual clinical practice (evidence-practice-gap). The purpose of this study was to develop an individual fitness score (IFS) formula that expresses the degree to which prescribers adhere to the Guidelines for Pharmacological Therapy of Schizophrenia in a simple manner, and to determine the validity of this formula from a survey of the prescriptions of the EGUIDE project participants'.
Methods: To establish appropriate scores, members discussed the proposed formula and then voted on them. The IFS formula developed was set up so that antipsychotic monotherapy would be given 100 points, with points deducted if concomitant or adjunctive antipsychotic medications were used, and a minimum score of 0. To validate this formula, prescriptions of hospitalized schizophrenic patients at admission and at discharge were scored and compared.
Result: IFS points vary and ranged from 0 to100. The average pre-admission score for all subjects was 45.6, and the average score at discharge was 54, those were significantly higher during discharge.
Conclusions: We developed an IFS formula, a tool to easily visualize the degree to which current prescriptions conform to the guidelines for the pharmacological treatment of schizophrenia.
Journal Title
Neuropsychopharmacology Reports
ISSN
2574173X
Publisher
The Japanese Society of Neuropsychopharmacology|John Wiley & Sons
Volume
42
Issue
4
Start Page
502
End Page
509
Published Date
2022-10-18
Rights
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences